These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 14663553)
1. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Gallate JE; Mallet PE; McGregor IS Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553 [TBL] [Abstract][Full Text] [Related]
2. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Gallate JE; McGregor IS Psychopharmacology (Berl); 1999 Mar; 142(3):302-8. PubMed ID: 10208323 [TBL] [Abstract][Full Text] [Related]
3. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Hargreaves GA; McGregor IS Alcohol Clin Exp Res; 2007 Nov; 31(11):1900-7. PubMed ID: 17877781 [TBL] [Abstract][Full Text] [Related]
4. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Gallate JE; Saharov T; Mallet PE; McGregor IS Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497 [TBL] [Abstract][Full Text] [Related]
5. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Rowland NE; Mukherjee M; Robertson K Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078 [TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats. Perfumi M; Santoni M; Cippitelli A; Ciccocioppo R; Froldi R; Massi M Alcohol Clin Exp Res; 2003 Oct; 27(10):1554-62. PubMed ID: 14574225 [TBL] [Abstract][Full Text] [Related]
7. Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Dean RL; Eyerman D; Todtenkopf MS; Turncliff RZ; Bidlack JM; Deaver DR Pharmacol Biochem Behav; 2012 Jan; 100(3):530-7. PubMed ID: 22056608 [TBL] [Abstract][Full Text] [Related]
8. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Hölter SM; Spanagel R Psychopharmacology (Berl); 1999 Aug; 145(4):360-9. PubMed ID: 10460312 [TBL] [Abstract][Full Text] [Related]
9. Rats on the grog: novel pharmacotherapies for alcohol craving. McGregor IS; Gallate JE Addict Behav; 2004 Sep; 29(7):1341-57. PubMed ID: 15345269 [TBL] [Abstract][Full Text] [Related]
10. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Solinas M; Goldberg SR Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567 [TBL] [Abstract][Full Text] [Related]
11. The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol. June HL; McCane SR; Zink RW; Portoghese PS; Li TK; Froehlich JC Psychopharmacology (Berl); 1999 Nov; 147(1):81-9. PubMed ID: 10591872 [TBL] [Abstract][Full Text] [Related]
12. Synergistic efects of opioid and cannabinoid antagonists on food intake. Kirkham TC; Williams CM Psychopharmacology (Berl); 2001 Jan; 153(2):267-70. PubMed ID: 11205430 [TBL] [Abstract][Full Text] [Related]
13. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Colombo G; Agabio R; Fà M; Guano L; Lobina C; Loche A; Reali R; Gessa GL Alcohol Alcohol; 1998; 33(2):126-30. PubMed ID: 9566474 [TBL] [Abstract][Full Text] [Related]
14. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Ciccocioppo R; Martin-Fardon R; Weiss F Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696 [TBL] [Abstract][Full Text] [Related]
15. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Stromberg MF; Mackler SA; Volpicelli JR; O'Brien CP Alcohol; 2001 Feb; 23(2):109-16. PubMed ID: 11331108 [TBL] [Abstract][Full Text] [Related]
16. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. McGregor IS; Dam KD; Mallet PE; Gallate JE Alcohol Alcohol; 2005; 40(1):35-45. PubMed ID: 15550450 [TBL] [Abstract][Full Text] [Related]
17. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone. Coonfield DL; Kiefer SW; Ferraro FM; Sinclair JD Behav Neurosci; 2004 Oct; 118(5):1089-96. PubMed ID: 15506891 [TBL] [Abstract][Full Text] [Related]
18. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice. Bahremand A; Shafaroodi H; Ghasemi M; Nasrabady SE; Gholizadeh S; Dehpour AR Epilepsy Res; 2008 Sep; 81(1):44-51. PubMed ID: 18502613 [TBL] [Abstract][Full Text] [Related]
19. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats. June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166 [TBL] [Abstract][Full Text] [Related]
20. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data. Maccioni P; Colombo G; Carai MA CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]